key: cord-0826715-5yxo8pit
authors: Gulati, Aishwarya; Lakhani, Paras
title: Interstitial lung abnormalities and pulmonary fibrosis in COVID-19 patients: a short-term follow-up case series
date: 2021-03-29
journal: Clin Imaging
DOI: 10.1016/j.clinimag.2021.03.030
sha: 982985f71312a8ad0889f37465216a71715c880c
doc_id: 826715
cord_uid: 5yxo8pit

Fibrotic lung changes are well-known complications of SARS, MERS, and ARDS from other causes and are anticipated in recovered COVID patients. However, there is limited data so far showing a temporal relationship between lung changes on imaging in the acute phase and follow-up imaging after recovery from the infection. We present 12 patients who demonstrate the development of interstitial lung changes and pulmonary fibrosis in the same distribution and pattern as the acute phase findings, up to 6 months after the acute infection, demonstrating a direct relationship between these changes and COVID-19 pneumonia.

As the world continues to grapple with the COVID-19 pandemic and the acute toll it has taken on our health system, there are expected long-term implications on recovered patients. Anecdotal evidence suggests that recuperated patients continue to suffer from fatigue, cognitive slowing, body aches, and difficulty breathing. Long-term studies with SARS, MERS, and ARDS have shown fibrotic lung changes in recovered patients and these are anticipated in COVID-19 patients as well (1, 2) . Given the substantial number of people affected, the burden of subsequent interstitial lung disease may be significant. We present 12 patients who demonstrate the development of interstitial lung changes and pulmonary fibrosis in the same distribution as the acute phase findings (3, 4) .

This was a HIPAA-compliant institutional review board-exempt retrospective review of patients with confirmed COVID pneumonia who were admitted into our urban multicenter health system with waived requirement of informed patient consent. Our Picture Archive and Communication System (PACS) was radiologists (AG, 2 years" experience; PL a cardiothoracic radiologist with 14 years" experience). Patients with known severe interstitial lung disease, without sequential acute phase and follow-up imaging, and without laboratory confirmation of COVID-19 were excluded. 12 patients meeting these criteria were identified. Pertinent patient information was gathered including demographics, comorbidities, risk factors for interstitial lung disease, disease course during hospitalization, and disease outcome. The most recent pre-infection imaging, acute infectious phase imaging, and recovery phase imaging findings of these patients was then compared and reviewed. Pertinent changes on CT included the following as defined by the The lack of other risk factors for interstitial lung disease, corresponding geographic distributions as acute changes, and the temporal relationship between the findings do indicate that pulmonary fibrosis can develop after COVID-19 pneumonia.

In the acute phase, COVID-19 pneumonia usually presents with bilateral, illdefined predominantly subpleural and peripheral GGOs most commonly in the lower lobes. Also seen are consolidation, GGOs with reticulation leading to crazy paving, microvascular dilation, fibrotic streaks, subpleural lines, solid nodules, and pleural effusions (6) (7) (8) (9) . Acute phase findings are seen to peak during days 6-14 of the infection (9, 10). At 3 weeks, Liu et al, found most of the patients had no residual lung disease, but over 40% had persistent GGOs or a fibrous stripe. They also observed that younger patients were more likely to have complete resolution of imaging findings 

Pulmonary fibrosis secondary to COVID-19: a call to arms?

Survivors: Predictive Factors and Risk Reduction Strategies

Fleischner Society: glossary of terms for thoracic imaging

Chest CT Findings Related to COVID-19. Endorsed by the Society of Thoracic Radiology, the American College of Radiology, and RSNA -Secondary Publication

CT Features of Coronavirus Disease

COVID-19) Pneumonia in 62 Patients in Wuhan, China

Radiological findings from 81 patients with COVID-19 pneumonia in Wuhan, China: a descriptive study

The pulmonary sequalae in discharged patients with COVID-19: a short-term observational study

Temporal radiographic changes in COVID-19 patients: relationship to disease severity and viral clearance

Temporal Changes of CT Findings in 90 Patients with COVID-19 Pneumonia: A Longitudinal Study

Pulmonary fibrosis in critical ill patients Discharged after Treatment for COVID-19 Pneumonia

Lung fibrosis: an undervalued finding in COVID-19 pathological series

Radiologic outcomes at 5 years after severe ARDS

Long-term bone and lung consequences associated with hospital-acquired severe acute respiratory syndrome: a 15-year follow-up from a prospective cohort study

Follow-up chest radiographic findings in patients with MERS-CoV after recovery

Longterm Respiratory Complication in Patients with Middle East Respiratory Syndrome: 1-year Follow-up After the